Girish Melkani, Ph.D., recently Promoted to professor in the Department of Pathology, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

About half of Americans between 45 and 84 have atherosclerosis without knowing it. Diseases linked to atherosclerosis are the leading cause of death in the United States. The condition develops when fats, cholesterol and other substances form plaque in the arteries. As plaque builds, arteries narrow and block blood flow, or can burst, which may lead to blood clotting. The initiation and progression of atherosclerosis are largely driven by genetic and environmental risk factors, but in between, how epigenetic regulation contributes to this pathogenesis remains largely unknown.

The UAB Department of Pathology recently funded travel awards to two trainees, Samar Kumar Halder and Dr. Kenneth Long, who will present their research at national meetings this year.

Michel Kmeid, M.D., an assistant professor in the Division of Anatomic Pathology, will serve as medical director of the gross room and frozen section lab, effective October 1.

The UAB Department of Pathology celebrated the 30th year of its Paulette Shirey Pritchett Endowed Lecture in Pathology on September 25 with an outstanding lecture by Mark T. Gladwin, M.D., Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, and the John Z. Akiko K. Bowers Distinguished Professor and Dean. Gladwin delivered the talk, titled, “Translating Redox Biology to Medicine: Lessons Learned, Taking Risks, and Going NO Where.”

Granzyme K (GzmK), a family of granzymes implicated in age-associated inflammatory disease, plays a key role in driving chronic inflammation by causing cell death. Despite its significant impact on diseases like asthma, psoriasis and atherosclerosis, current therapies lack focus on GzmK.

Several Research and Clinical Experience in Pathology (RaCE4Path) students presented posters at the 2025 UAB Heersink School of Medicine Dale J Benos Medical Student Research Day on September 15 and the UAB Undergraduate Research Expo on July 24.

In 2016, the rare disease Zhu-Tokita-Takenouchi-Kim, or ZTTK Syndrome, was discovered by Erin Eun Young Ahn, Ph.D., a professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, alongside her research team. ZTTK is primarily identified in children and is characterized by intellectual disability, delayed musculoskeletal development and multi-organ anomalies, and is caused by loss of function in the SON gene. This gene creates a DNA and RNA binding protein, SON, that is required for the body to grow and develop naturally.

The UAB Department of Pathology boasts a long legacy of fostering physician-scientists who are skilled both in clinical practice and research. These practitioners bridge the crucial gap between the lab and patient care, using clinical experience to drive research leading to new treatments and therapies. Their efforts target individualized medicine, propel public health breakthroughs and ensure that scientific discoveries are translated directly to the bedside.

The Department of Pathology is pleased to announce the promotion and tenure of eight of our esteemed faculty colleagues for 2025, effective October 1, 2025. 

Falone Amoa, M.D., M.S., PGY5, and Damien Roland, M.D., M.S., PGY3, were recently named 2025 Future of Pathology Award recipients by the National Medical Association. The Future of Pathology Award was established in 2020 with the goal to recognize and reward minority students and trainees who have a special interest in the field of pathology.

Rati Chkheidze, M.D., an assistant professor in the Division of Neuropathology, has been appointed section head of neuropathology, effective July 1. Chkheidze joined the UAB Department of Pathology in 2020 from the University of Texas Southwestern Medical Center, where he completed a neuropathology fellowship following his anatomic and clinical pathology residency. Originally from the country of Georgia, he graduated from Tbilisi State Medical University in 2007. Before joining the University of Texas Southwestern Medical Center, he worked as a senior visiting scientist in the Department of Neurology and Neurotherapeutics until 2014. His research interests focus on image analysis and machine learning applications in neurodegenerative and tumor neuropathology, and brain banking.  

Peter Anderson, D.V.M., Ph.D., professor emeritus in the Division of Molecular and Cellular Pathology, delivered one of the inaugural lectures for a new certificate program offered by the Association of Academic Pathology (AAPath) at its annual meeting in Denver, Colorado, in July. This program is designed for health science faculty at all levels of experience who seek professional development to enhance their teaching effectiveness, expand their knowledge and expertise in curricular development and advance their careers as health science educators.

Adeyi Oyedele, M.D., FRCPC, Division Director, Anatomic Pathology, will serve as section head of Gastrointestinal Pathology and director of the GI fellowship program, effective July 15.  

Falone Amoa, M.D., M.S., a PGY5 and Ph.D. candidate in the UAB Department of Pathology, has recently been named a Society of '67 Kinney Scholar by the Association for Academic Pathology (AAPath). This award is for pathology residents and medical students who demonstrate the potential for leadership in academic pathology. Amoa is 1 of 5 residents and 8 medical students selected from across the United States. 

The Department of Pathology is thrilled to announce a new faculty member joining our team August 1.

UAB ENhancing Research In Cancer-related Health professions (ENRICH) successfully completed its second year of the rigorous 10-week summer program to engage in cancer research at UAB.

Michel Kmeid, M.D., will join the Division of Anatomic Pathology as an assistant professor, effective August 1. Kmeid joins us from the Cleveland Clinic Foundation in Ohio, where he served as a head and neck pathology fellow since 2024.

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is. Mycoplasmas are the smallest free-living organisms. They can cause drug-resistant bacterial infections that target various parts of the body, including respiratory and urinary systems and genitalia. Mycoplasmas commonly cause lung infections and often require a special antibiotic to treat the bacterium. Most antibiotics weaken bacteria by penetrating their cell walls. Mycoplasmas, however, don’t have cell walls to weaken.

Peripheral artery disease is a severe form of cardiovascular disease affecting more than 230 million individuals worldwide. The correlation of peripheral artery disease with diminished blood flow in one or more major arteries has prompted numerous studies aimed at developing therapies that promote the formation of new mature blood vessels, known as neovessels, to restore blood flow. However, despite years of investigations, the medical therapies designed to do so have lacked therapeutic significance.